A left breast mass was detected on clinical examination, and subsequent imaging and biopsy confirmed human epidermal growth factor receptor 2 (HER2)-positive, hormone receptor-negative invasive ductal carcinoma. The gene discussed is ERBB2; the disease is invasive ductal breast carcinoma.